CRISPR interference screens in ALK+ anaplastic large cell lymphoma cell culture (SU-DHL-1) under treatment with therapies used in peripheral T-cell lymphoma treatment
Ontology highlight
ABSTRACT: The following are raw Illumina sequencing files for 14-day genome-wide CRISPR interference screens conducted in a T-cell lymphoma cell culture. This submission contains the results of two sets of genome-wide screens conducted at the University of North Carolina at Chapel Hill School of Medicine, in the lab of Adam Palmer. SU-DHL-1 cells stably expressing dCas9-KRAB (Addgene # 110820) were transduced with pCRISPRi-v2 genome-wide library (Addgene #84832) and treated for 14-days with either pralatrexate, romidepsin, oxaliplatin, gemcitabine, or bortezomib. Deposited here are the raw high-throughput sequencing files, and the processed gene tables with phenotype scores, generated using the CRISPR interference screen data analysis pipeline originally published by Max Horlbeck from the lab of Jonathan Weissman.
ORGANISM(S): Homo sapiens
PROVIDER: GSE330619 | GEO | 2026/05/15
REPOSITORIES: GEO
ACCESS DATA